ZYVERSA THERAPEUTICS INC (ZVSA) is a publicly traded PHARMACEUTICAL PREPARATIONS sector company. As of July 11, 2026, ZVSA trades at $0.31 with a market cap of $0 and a P/E ratio of -0.04. ZVSA moved -43.40% today. Year to date, ZVSA is -72.93%; over the trailing twelve months it is -92.94%. Its 52-week range spans $0.27 to $42.39. Analyst consensus is buy with an average price target of $0.00. Rallies surfaces ZVSA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover ZVSA: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $0.00.
| Metric | Value |
|---|---|
| Price | $0.31 |
| Market Cap | $0 |
| P/E Ratio | -0.04 |
| EPS | $-8.48 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.39 |
| 52-Week Low | $0.27 |
| Volume | 12.45M |
| Avg Volume | 0 |
| Revenue (TTM) | $-269.86K |
| Net Income | $-9.41M |
| Gross Margin | 0.00% |
1 analysts cover ZVSA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $0.00.